Back to Research Home
DVADaVita HealthCare Partners Inc
Health Care · Health Care Services · Large
$183.64−1.32%
As of 23 Oct 2026Mkt cap $11.4B
Stage 13
WAIT
Fundamentals
46.9/75
Technical
6.8/15
Independent
53.7/90
GCAE viewelevated earnings event risk blocks an independent BUY decision
Price
- 1M
- +5.1%
- 3M
- −22.3%
- 6M
- +20.9%
- 1Y
- +42.3%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 15.0xHist median 14.6x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 8.7x
- FCF yield
- 11.6%
Quality
- ROIC
- 17.4%
- Operating margin
- 15.0%
- FCF margin
- 9.6%
- Current ratio
- 1.3x
Growth
- Revenue growth
- +6.5%Latest FY YoY
- Revenue CAGR
- +4.1%
- EPS CAGR
- +2.5%
- FCF CAGR
- +0.4%
Capital
- Share-count trend
- −9.8%3Y annualised
- Net debt
- $9.7B5.1x OCF
Annual trend
- CAGR 2021–2025
- +4.1%
- Latest · 2025
- $14B
- YoY
- +6.5%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- FUNDAMENTAL GATE FAIL
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
elevated earnings event risk blocks an independent BUY decision
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-10-29
More details & evidence
Production decision
- Stage 13
- WAIT
- Technical state
- approaching-support
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded